Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

Dr John Isaac

Project Lead, Synaptic Health

John is Senior Director in Neuroscience at Johnson & Johnson Innovation. Prior to joining Johnson & Johnson, John was Head of Neuroscience and Mental Health at the Wellcome Trust.

John co-leads two DPUK Work Packages within the Experimental Medicine Incubator's Synaptic Health theme. Those are Work Package 26a: Synaptic loss and its functional consequences in early Alzheimer's disease, using pre-synaptic markers and magnetoencephalography; and Work Package 26b: Synaptic loss and its functional consequences in early Alzheimer's disease, using a new post-synaptic TARP γ8 AMPAR ligand.